Diazyme Laboratories, Inc. acquired Alfa Wassermann Diagnostic Technologies, according to source material published on October 14, 2026. The source identifies CARR Biosystems as the seller. This summary is limited to the approved transaction facts in the cited source evidence.
Diazyme Laboratories, Inc. acquired Alfa Wassermann Diagnostic Technologies
Diazyme Laboratories, Inc. acquired Alfa Wassermann Diagnostic Technologies
AcquisitionManufacturingUS
Get the full Alfa Wassermann Diagnostic Technologies company profile
Access contacts, investors, buying signals & more
Acquired
Alfa Wassermann Diagnostic Technologies
United StatesManufacturing
Undisclosed amount
October 14, 2026
Acquirer
Diazyme Laboratories, Inc.
Biotechnology Research
Unlock GTM signals
Discover Alfa Wassermann Diagnostic Technologies's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Alfa Wassermann Diagnostic Technologies.